Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Gutmann

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Cancer Research|April 28, 2001
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomasH Ding, L Roncari, P Shannon, et al.
Human Molecular Genetics|July 11, 2000
Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomasD H Gutmann, J Donahoe, A Perry, et al.
Veterinary Pathology|May 12, 2009
Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomasP J Dickinson, E I Surace, M Cambell, et al.
Oncogene|April 15, 2008
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomasH Deshmukh, T H Yeh, J Yu, et al.
Molecular and Cellular Biology|January 1, 1993
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activityL B Andersen, R Ballester, D A Marchuk, et al.
Nature Genetics|February 1, 1993
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell linesL B Andersen, J W Fountain, D H Gutmann, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 2001
Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 casesA Perry, C Giannini, R Raghavan, et al.
Familial Cancer|July 26, 2012
Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomasK J Johnson, M J Fisher, R L Listernick, et al.
Neurology|July 24, 2002
Neurofibromatosis 2 and malignant mesotheliomaM E Baser, A De Rienzo, D Altomare, et al.
International Journal of Oncology|February 20, 1999
Establishment of primary vestibular schwannoma cultures from neurofibromatosis type-2 patientsG Hung, R Faudoa, X Li, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Cancer Research|April 28, 2001
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomasH Ding, L Roncari, P Shannon, et al.
Human Molecular Genetics|July 11, 2000
Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomasD H Gutmann, J Donahoe, A Perry, et al.
Veterinary Pathology|May 12, 2009
Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomasP J Dickinson, E I Surace, M Cambell, et al.
Oncogene|April 15, 2008
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomasH Deshmukh, T H Yeh, J Yu, et al.
Molecular and Cellular Biology|January 1, 1993
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activityL B Andersen, R Ballester, D A Marchuk, et al.
Nature Genetics|February 1, 1993
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell linesL B Andersen, J W Fountain, D H Gutmann, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 2001
Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 casesA Perry, C Giannini, R Raghavan, et al.
Familial Cancer|July 26, 2012
Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomasK J Johnson, M J Fisher, R L Listernick, et al.
Neurology|July 24, 2002
Neurofibromatosis 2 and malignant mesotheliomaM E Baser, A De Rienzo, D Altomare, et al.
International Journal of Oncology|February 20, 1999
Establishment of primary vestibular schwannoma cultures from neurofibromatosis type-2 patientsG Hung, R Faudoa, X Li, et al.
Pageof 13